Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients

Palmieri, C, Stein, RC, Liu, X et al. (12 more authors) (2018) Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. Breast Cancer Research and Treatment, 167 (1). p. 407. ISSN 0167-6806

Metadata

Authors/Creators:
Commentary on: Palmieri, C, Stein, RC, Liu, X et al. (12 more authors) (2017) IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. Breast Cancer Research and Treatment, 165 (2). pp. 343-353. ISSN 0167-6806
Copyright, Publisher and Additional Information: © Springer Science+Business Media, LLC 2017.
Dates:
  • Published: January 2018
  • Accepted: 25 October 2017
  • Published (online): 25 October 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 23 Jan 2018 12:12
Last Modified: 26 Jul 2018 13:05
Status: Published
Publisher: Springer Verlag
Identification Number: https://doi.org/10.1007/s10549-017-4539-3

Commentary/Response Threads

Share / Export

Statistics